author_facet Hua, Liyan
Chiang, Chien‐Wei
Cong, Wang
Li, Jin
Wang, Xueying
Cheng, Lijun
Feng, Weixing
Quinney, Sara K.
Wang, Lei
Li, Lang
Hua, Liyan
Chiang, Chien‐Wei
Cong, Wang
Li, Jin
Wang, Xueying
Cheng, Lijun
Feng, Weixing
Quinney, Sara K.
Wang, Lei
Li, Lang
author Hua, Liyan
Chiang, Chien‐Wei
Cong, Wang
Li, Jin
Wang, Xueying
Cheng, Lijun
Feng, Weixing
Quinney, Sara K.
Wang, Lei
Li, Lang
spellingShingle Hua, Liyan
Chiang, Chien‐Wei
Cong, Wang
Li, Jin
Wang, Xueying
Cheng, Lijun
Feng, Weixing
Quinney, Sara K.
Wang, Lei
Li, Lang
CPT: Pharmacometrics & Systems Pharmacology
The Cancer Drug Fraction of Metabolism Database
Pharmacology (medical)
Modeling and Simulation
author_sort hua, liyan
spelling Hua, Liyan Chiang, Chien‐Wei Cong, Wang Li, Jin Wang, Xueying Cheng, Lijun Feng, Weixing Quinney, Sara K. Wang, Lei Li, Lang 2163-8306 2163-8306 Wiley Pharmacology (medical) Modeling and Simulation http://dx.doi.org/10.1002/psp4.12417 <jats:p>This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the <jats:styled-content style="fixed-case">US </jats:styled-content> Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate‐depletion and metabolite‐formation data from publicly available <jats:italic>in vitro</jats:italic> selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an <jats:italic>in vitro</jats:italic> drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios &gt; 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 <jats:styled-content style="fixed-case">drug–drug interaction</jats:styled-content> pairs.</jats:p> The Cancer Drug Fraction of Metabolism Database CPT: Pharmacometrics & Systems Pharmacology
doi_str_mv 10.1002/psp4.12417
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9wc3A0LjEyNDE3
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9wc3A0LjEyNDE3
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
issn 2163-8306
issn_str_mv 2163-8306
language English
mega_collection Wiley (CrossRef)
match_str hua2019thecancerdrugfractionofmetabolismdatabase
publishDateSort 2019
publisher Wiley
recordtype ai
record_format ai
series CPT: Pharmacometrics & Systems Pharmacology
source_id 49
title The Cancer Drug Fraction of Metabolism Database
title_unstemmed The Cancer Drug Fraction of Metabolism Database
title_full The Cancer Drug Fraction of Metabolism Database
title_fullStr The Cancer Drug Fraction of Metabolism Database
title_full_unstemmed The Cancer Drug Fraction of Metabolism Database
title_short The Cancer Drug Fraction of Metabolism Database
title_sort the cancer drug fraction of metabolism database
topic Pharmacology (medical)
Modeling and Simulation
url http://dx.doi.org/10.1002/psp4.12417
publishDate 2019
physical 511-519
description <jats:p>This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the <jats:styled-content style="fixed-case">US </jats:styled-content> Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate‐depletion and metabolite‐formation data from publicly available <jats:italic>in vitro</jats:italic> selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an <jats:italic>in vitro</jats:italic> drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios &gt; 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 <jats:styled-content style="fixed-case">drug–drug interaction</jats:styled-content> pairs.</jats:p>
container_issue 7
container_start_page 511
container_title CPT: Pharmacometrics & Systems Pharmacology
container_volume 8
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333623773364228
geogr_code not assigned
last_indexed 2024-03-01T14:15:42.768Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Cancer+Drug+Fraction+of+Metabolism+Database&rft.date=2019-07-01&genre=article&issn=2163-8306&volume=8&issue=7&spage=511&epage=519&pages=511-519&jtitle=CPT%3A+Pharmacometrics+%26+Systems+Pharmacology&atitle=The+Cancer+Drug+Fraction+of+Metabolism+Database&aulast=Li&aufirst=Lang&rft_id=info%3Adoi%2F10.1002%2Fpsp4.12417&rft.language%5B0%5D=eng
SOLR
_version_ 1792333623773364228
author Hua, Liyan, Chiang, Chien‐Wei, Cong, Wang, Li, Jin, Wang, Xueying, Cheng, Lijun, Feng, Weixing, Quinney, Sara K., Wang, Lei, Li, Lang
author_facet Hua, Liyan, Chiang, Chien‐Wei, Cong, Wang, Li, Jin, Wang, Xueying, Cheng, Lijun, Feng, Weixing, Quinney, Sara K., Wang, Lei, Li, Lang, Hua, Liyan, Chiang, Chien‐Wei, Cong, Wang, Li, Jin, Wang, Xueying, Cheng, Lijun, Feng, Weixing, Quinney, Sara K., Wang, Lei, Li, Lang
author_sort hua, liyan
container_issue 7
container_start_page 511
container_title CPT: Pharmacometrics & Systems Pharmacology
container_volume 8
description <jats:p>This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the <jats:styled-content style="fixed-case">US </jats:styled-content> Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate‐depletion and metabolite‐formation data from publicly available <jats:italic>in vitro</jats:italic> selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an <jats:italic>in vitro</jats:italic> drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios &gt; 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 <jats:styled-content style="fixed-case">drug–drug interaction</jats:styled-content> pairs.</jats:p>
doi_str_mv 10.1002/psp4.12417
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9wc3A0LjEyNDE3
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 2163-8306
issn_str_mv 2163-8306
language English
last_indexed 2024-03-01T14:15:42.768Z
match_str hua2019thecancerdrugfractionofmetabolismdatabase
mega_collection Wiley (CrossRef)
physical 511-519
publishDate 2019
publishDateSort 2019
publisher Wiley
record_format ai
recordtype ai
series CPT: Pharmacometrics & Systems Pharmacology
source_id 49
spelling Hua, Liyan Chiang, Chien‐Wei Cong, Wang Li, Jin Wang, Xueying Cheng, Lijun Feng, Weixing Quinney, Sara K. Wang, Lei Li, Lang 2163-8306 2163-8306 Wiley Pharmacology (medical) Modeling and Simulation http://dx.doi.org/10.1002/psp4.12417 <jats:p>This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the <jats:styled-content style="fixed-case">US </jats:styled-content> Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate‐depletion and metabolite‐formation data from publicly available <jats:italic>in vitro</jats:italic> selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an <jats:italic>in vitro</jats:italic> drug interaction prediction for the 42 cancer drugs. In the drug–drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios &gt; 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 <jats:styled-content style="fixed-case">drug–drug interaction</jats:styled-content> pairs.</jats:p> The Cancer Drug Fraction of Metabolism Database CPT: Pharmacometrics & Systems Pharmacology
spellingShingle Hua, Liyan, Chiang, Chien‐Wei, Cong, Wang, Li, Jin, Wang, Xueying, Cheng, Lijun, Feng, Weixing, Quinney, Sara K., Wang, Lei, Li, Lang, CPT: Pharmacometrics & Systems Pharmacology, The Cancer Drug Fraction of Metabolism Database, Pharmacology (medical), Modeling and Simulation
title The Cancer Drug Fraction of Metabolism Database
title_full The Cancer Drug Fraction of Metabolism Database
title_fullStr The Cancer Drug Fraction of Metabolism Database
title_full_unstemmed The Cancer Drug Fraction of Metabolism Database
title_short The Cancer Drug Fraction of Metabolism Database
title_sort the cancer drug fraction of metabolism database
title_unstemmed The Cancer Drug Fraction of Metabolism Database
topic Pharmacology (medical), Modeling and Simulation
url http://dx.doi.org/10.1002/psp4.12417